Molecular Partners Balance Sheet Health
Financial Health criteria checks 6/6
Molecular Partners has a total shareholder equity of CHF138.8M and total debt of CHF0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CHF154.2M and CHF15.4M respectively.
Key information
0%
Debt to equity ratio
CHF 0
Debt
| Interest coverage ratio | n/a |
| Cash | CHF 143.62m |
| Equity | CHF 138.78m |
| Total liabilities | CHF 15.43m |
| Total assets | CHF 154.21m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MLLC.F's short term assets (CHF149.5M) exceed its short term liabilities (CHF10.4M).
Long Term Liabilities: MLLC.F's short term assets (CHF149.5M) exceed its long term liabilities (CHF5.0M).
Debt to Equity History and Analysis
Debt Level: MLLC.F is debt free.
Reducing Debt: MLLC.F had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MLLC.F has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: MLLC.F has sufficient cash runway for 1.9 years if free cash flow continues to reduce at historical rates of 1.7% each year.